Evolus, Inc. Common Stock
Veridion Score
Composite trend over time
Why is EOLS moving today?
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for EOLS.
EOLS insider activity
Evolus, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for EOLS.
EOLS contract awards, year to date.
Public federal awards linked to this ticker.
EOLS lobbying filings, year to date.
Registered lobbying filings matched to Evolus, Inc. Common Stock.